Perrigo Company PLC (NYSE:PRGO)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $63.50 and last traded at $64.09, with a volume of 341305 shares changing hands. The stock had previously closed at $75.14.
A number of equities analysts have recently issued reports on the stock. Royal Bank of Canada set a $63.00 price objective on shares of Perrigo and gave the company a “hold” rating in a research note on Friday. ValuEngine cut shares of Perrigo from a “sell” rating to a “strong sell” rating in a research note on Thursday. Cantor Fitzgerald restated a “buy” rating and issued a $107.00 price objective on shares of Perrigo in a research note on Monday, October 8th. Wells Fargo & Co dropped their price objective on shares of Perrigo from $84.00 to $77.00 and set a “market perform” rating for the company in a research note on Tuesday, August 21st. Finally, Canaccord Genuity set a $90.00 price objective on shares of Perrigo and gave the company a “buy” rating in a research note on Friday, August 17th. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $87.80.
The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.23 and a current ratio of 1.81. The firm has a market capitalization of $10.28 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 2.43 and a beta of 0.66.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 18th. Stockholders of record on Friday, November 30th will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 1.19%. The ex-dividend date is Thursday, November 29th. Perrigo’s payout ratio is 15.42%.
In related news, EVP Svend Andersen acquired 3,900 shares of the firm’s stock in a transaction on Friday, November 9th. The shares were purchased at an average price of $63.01 per share, with a total value of $245,739.00. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP Todd W. Kingma acquired 3,200 shares of the firm’s stock in a transaction on Friday, November 9th. The shares were bought at an average cost of $63.99 per share, for a total transaction of $204,768.00. Following the acquisition, the vice president now owns 23,587 shares in the company, valued at $1,509,332.13. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 29,983 shares of company stock worth $1,950,822. 6.90% of the stock is owned by insiders.
Large investors have recently modified their holdings of the business. Piedmont Investment Advisors LLC bought a new stake in Perrigo during the 2nd quarter worth about $110,000. NuWave Investment Management LLC grew its holdings in Perrigo by 17,377.8% during the 3rd quarter. NuWave Investment Management LLC now owns 1,573 shares of the company’s stock worth $111,000 after acquiring an additional 1,564 shares during the last quarter. Dupont Capital Management Corp grew its holdings in Perrigo by 63.8% during the 2nd quarter. Dupont Capital Management Corp now owns 1,705 shares of the company’s stock worth $124,000 after acquiring an additional 664 shares during the last quarter. Allianz Asset Management GmbH bought a new stake in Perrigo during the 1st quarter worth about $205,000. Finally, Exane Asset Management bought a new stake in Perrigo during the 2nd quarter worth about $205,000. 83.00% of the stock is currently owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: “Perrigo (PRGO) Sets New 52-Week Low at $63.50” was published by Week Herald and is the property of of Week Herald. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://weekherald.com/2018/11/10/perrigo-prgo-sets-new-52-week-low-at-63-50.html.
About Perrigo (NYSE:PRGO)
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
See Also: Google Finance Portfolio Workaround
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.